Tejara Capital’s Collegium Pharmaceutical COLL Stock Holding History

Tejara Capital’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-77,000	Closed	-$2.55M	–	68
2026 Q1	$2.55M	Buy	+77,000	New	+$3.26M	0.84%	38
2025 Q3	–	Sell	-107,337	Closed	-$3.17M	–	56
2025 Q2	$3.17M	Sell	107,337 -4,455	-4%	-$127K	1.47%	25
2025 Q1	$3.34M	Buy	111,792 +83,011	+288%	+$2.54M	1.29%	21
2024 Q4	$825K	Buy	+28,781	New	+$952K	0.54%	40
2024 Q3	–	Sell	-124,700	Closed	-$4.02M	–	63
2024 Q2	$4.02M	Buy	+124,700	New	+$4.32M	1.46%	24
2024 Q1	–	Sell	-141,099	Closed	-$4.34M	–	82
2023 Q4	$4.34M	Sell	141,099 -148,704	-51%	-$3.72M	1.82%	21
2023 Q3	$6.48M	Sell	289,803 -14,886	-5%	-$340K	3.67%	9
2023 Q2	$6.55M	Buy	304,689 +47,228	+18%	+$1.07M	3.22%	9
2023 Q1	$6.18M	Buy	257,461 +136,681	+113%	+$3.62M	3.16%	9
2022 Q4	$2.8M	Buy	+120,780	New	+$2.44M	1.61%	18

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Tejara Capital's COLL Position: Q2 2026 in Review

Tejara Capital sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 77,000 shares — an estimated $2.55M sold.

Tejara Capital first reported a position in COLL in Q4 2022 and held it in 10 quarters. The position peaked at $6.55M in Q2 2023. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Tejara Capital reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Tejara Capital sold 77,000 Collegium Pharmaceutical shares in Q2 2026, an estimated $2.55M.
Tejara Capital first reported a position in Collegium Pharmaceutical in Q4 2022 and held it in 10 quarters.
Tejara Capital's Collegium Pharmaceutical position peaked at $6.55M in Q2 2023.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Tejara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.